Some include the discovery of the basis of amniocentesis and new fertility treatments; the founding of two leading treatments for Multiple Sclerosis (MS) called Copaxone® and Rebif®; and the development of advanced image scanning technology. Currently under development are vaccines for flu and diabetes; growing new organs and T cells to treat damaged spines from stem cells; and finding out how diseases originated. Discovering how medicine and therapies will evolve is also a key focus: personalised medicine that provides treatments and therapies based on the individual’s genetic make-up are the future, and Weizmann’s new Nancy and Stephen Grand Israel National Center for Personalized Medicine is working hard to make this a reality. In Australia, Weizmann collaborations with leading universities have also played a role in understanding the basis of disease in a bid to develop better treatments and help our world to become a healthier place. Weizmann has recently joined forces with Australia’s famous Garvan Institute of Medical Research to establish the Garvan-Weizmann Centre for Cellular Genomics where these two great research centres will create synergistic research platforms to advance cellular genomic science.
Leading MS drugs Copaxone® and Rebif® developed by Weizmann, treating some of the 23,700 Australians with MS
A type 1 (juvenile) diabetes treatment is now in Phase III clinical trials
Deciphered 3-billion-base-pair genome in its role as part of the Human Genome Project
Weizmann Scientists – led by Professor Dan Tawfik – have designed artificial enzymes that can evolve in a test tube at faster rates, opening doors for different applications in medicine and industry.
The cause of brain damage from injury is from glutamate, a neurotransmitter that floods the brain when such an event occurs. A method the makes this excess glutamate leave the brain quickly and safely into the blood stream has been developed by Weizmann’s Professor Vivian Teichberg.
Now used around the world, the process of performing a uterine biopsy before in vitro fertilization was found by Weizmann’s Professor Nava Dekel to double the chance of pregnancy success.
An international crowd-sourced campaign to discover an anti-COVID-19 drug has created a blueprint for the accelerated, patent-free development of drugs to treat viral threats to humanity. The results of the…
A research team headed by Professor Jacob Hanna at the Weizmann Institute of Science has created complete models of human embryos from stem cells cultured in the lab – and…
A new study in mice could pave the way to personalised therapy for depression, anxiety and other stress-related disorders known to produce different effects on men and women. Scientific excellence…
Mysterious macrophages, found to rapidly digest dying B cells, may hold clues to future treatments of autoimmune disorders new Weizmann research shows. Parents tell their children to eat all the…
Weizmann’s research into advanced technology is immense and acts as a time line for technology’s evolution.
Nearly half the life science research at the Weizmann Institute of Science in Israel is focussed on cancer.
Although over the centuries we have learned much about our physical world, from the earth below to the stars above, there are still many mysteries to uncover.
Providing solutions to our planet’s environmental challenges is part of Weizmann’s business.
Science education is a core endeavour of the Weizmann Institute of Science.